Exelon, Rivastigmine Wire
Comprehensive News Feed for Exelon, Rivastigmine (generic).
Results 1 - 16 of 16 in Exelon, Rivastigmine (generic)
-
Alzheimer's: love as effective as medicine
Love as effective as medicine for Alzheimer's? Researchers have found evidence that the physical and mental decline of Alzheimer's patients was slower for patients who have a close relationship with their caregivers. Comment?
-
Health trusts 'failing to cut use of 'chemical cosh' drugs'
w/Photo
Anti-psychotic drugs, which are recommended in the short-term to calm down people who are agitated or violent, are known to be overprescribed, particularly in care homes. Comment?
-
Cholinesterase inhibitors may raise bradycardia risk
Cholinesterase inhibitor therapy, commonly used to treat Alzheimer's disease and related dementias, significantly increases the risk of hospital admission for bradycardia, according to results of a Canadian study published in the online journal PLoS Medicine. Comment?
-
Alzheimer's medication may increase risk of abnormally slow heart rate
Washington, October 2 : A medication that is commonly prescribed to treat Alzheimer's disease can increase a person's risk of being hospitalised for a potentially serious condition called bradycardia, say researchers. Comment?
-
Risk from Medications Used To Treat Alzheimer's
w/Photo
New research discovers one of the medications commonly prescribed to treat Alzheimer's disease may be more dangerous than previously thought. Comment?
-
Risk Of Abnormally Slow Heart Rate Twice As High In Those Taking Drugs To Slow Alzheimer's
Researchers from St. Michael's Hospital and Ontario's Institute for Clinical Evaluative Sciences analyzed data from 1.4 million people aged 67 and older to see whether the risk for bradycardia was higher for those taking drugs called cholinesterase inhibitors. Comment?
-
'Morally wrong' to deny dementia patients support - report
w/Photo
Published by Jon Land for 24dash.com in Communities , Health Thursday 1st October 2009 - 8:47am 'Morally wrong' to deny dementia patients support - report It is "morally wrong" to diagnose people with dementia and then leave them with no support, a report said today. Comment?
-
Students turn to 'smart drugs' to boost grades
w/Photo
Students are using smart drugs to boost the performance of their brains. Photograph: Howard Sochurek/Corbis Students are increasingly using brain-boosting drugs a ' and they're virtually impossible to ban, an expert warned today. Comment?
-
Battlefield Alzheimer's
w/Photo
A look at the symptoms of Alzheimer's and the treatments currently available. It is important that the diagnosis of Alzheimer's be confirmed by consulting a physician, neurologist, psychiatrist or geriatrician. Comment?
-
Drugs to treat dementia wanted on NHF list
The following is extracted from a letter written to the National Health Fund on May 25, 2009, by Dr Loraine Barnaby while she was consultant psychiatrist in the Dementia Clinic at the University Hospital of the West Indies. Comment?
-
Row over seizure of low-cost drugs
A global controversy has arisen over the seizure of low-cost generic medicine in European ports in transit from India to other developing countries. Comment?
-
Chemoenzymatic Synthesis of Rivastigmine Based on Lipase-Catalyzed Processes
NEW Abstract A straightforward chemoenzymatic synthesis of enantiomerically pure rivastigmine has been efficiently carried out under mild reaction conditions, with Candida antarctica lipase B responsible for the stereoselective acetylation of the corresponding -alcohol or amine. Comment?
-
Alzheimer's drugs slow progression of disease
Medication can improve the quality of life for people with Alzheimer's and their caregivers. Comment?
-
Neuropsychology Abstract of the Day: Alzheimer Drug Regimens & Delivery Systems
Bassil, N & Grossberg, GT. . Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease. Comment?
-
Close Caregiver Relationship May Slow Alzheimer's Progress
Caregivers of Alzheimera s patients who have an especially close relationship with their patients may have a positive impact on decline of the disease. Comment?
-
EnVivo Pharmaceuticals Announces Results and Successful Completion of ...
EnVivo Pharmaceuticals today announced the successful completion of a phase Ib/IIa trial in Alzheimer's disease patients with its nicotinic alpha-7 agonist EVP-6124. Subjects receiving EVP-6124 experienced improvement in cognition and EVP-6124 showed good tolerability and safety. Comment?
- « Previous
- 1
- Next »
Exelon, Rivastigmine Forum
Most Popular
- The Europe Union is discriminating Muslims - 560 comments
- Merry Christmas: Mary J. Blige Punches Out Husband In Public; Rep calls it 'a... - 197 comments
- McCain: Dems Will Pay Dearly - 149 comments
- New Salad bar in Harlem - 90 comments
- Hate crimes against gays rose 11% - 287 comments
- Terrorist Attack Upon Northwest Airlines Flight On Christmas Day - 124 comments
- Catholic Officials Fomenting Anti-Gay Violence In Mexico - 116 comments
- Inmate on suicide watch commits suicide - 63 comments
- US plane incident an 'attempted act of terrorism': official - 80 comments
- Woman Knocks Over Pope Benedict XVI At Christmas Eve Mass (incl. Video) - 68 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
